A citation-based method for searching scientific literature

Jianchun Wu, David L Crowe. Mol Cancer Res 2020
Times Cited: 2







List of co-cited articles
articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Telomere repeat-binding factor 2 binds extensively to extra-telomeric G-quadruplexes and regulates the epigenetic status of several gene promoters.
Ananda Kishore Mukherjee, Shalu Sharma, Sulochana Bagri, Rintu Kutum, Pankaj Kumar, Asgar Hussain, Prateek Singh, Dhurjhoti Saha, Anirban Kar, Debasis Dash,[...]. J Biol Chem 2019
10
50


Expression of Telomere Repeat Binding Factor 1 and TRF2 in Prostate Cancer and Correlation with Clinical Parameters.
Wei Chen, Yong Wang, Fei Li, Wei Lin, Yong Liang, Zhiwei Ma. Biomed Res Int 2017
9
50

The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity.
Jordi Barretina, Giordano Caponigro, Nicolas Stransky, Kavitha Venkatesan, Adam A Margolin, Sungjoon Kim, Christopher J Wilson, Joseph Lehár, Gregory V Kryukov, Dmitriy Sonkin,[...]. Nature 2012
50


Downregulation of zinc finger protein 132 in prostate cancer is associated with aberrant promoter hypermethylation and poor prognosis.
Mette Opstrup Abildgaard, Michael Borre, Martin Mørck Mortensen, Benedicte P Ulhøi, Niels Tørring, Peter Wild, Helle Kristensen, Francisco Mansilla, Peter D Ottosen, Lars Dyrskjøt,[...]. Int J Cancer 2012
18
50

Telosome, a mammalian telomere-associated complex formed by multiple telomeric proteins.
Dan Liu, Matthew S O'Connor, Jun Qin, Zhou Songyang. J Biol Chem 2004
287
50


Telomere shortening is an early somatic DNA alteration in human prostate tumorigenesis.
Alan K Meeker, Jessica L Hicks, Elizabeth A Platz, Gerrun E March, Christina J Bennett, Michael J Delannoy, Angelo M De Marzo. Cancer Res 2002
197
50


Growth, telomere dynamics and successful and unsuccessful human aging.
Abraham Aviv, Daniel Levy, Marc Mangel. Mech Ageing Dev 2003
42
50

Expressing the human genome.
R Tupler, G Perini, M R Green. Nature 2001
259
50

Androgen receptors and hormone sensitivity of a human prostatic cancer cell line (PC-3) are modulated by natural beta-interferon.
G Sica, G Dell'Acqua, F Iacopino, A Fattorossi, P Marchetti, T H van der Kwast, M Pavone-Macaluso. Urol Res 1994
15
50

Telomeres and telomerase in prostate cancer development and therapy.
Mindy Kim Graham, Alan Meeker. Nat Rev Urol 2017
35
50

MicroRNA-23b and microRNA-27b plus flutamide treatment enhances apoptosis rate and decreases CCNG1 expression in a castration-resistant prostate cancer cell line.
Ruan Ca Pimenta, Nayara I Viana, Gabriela Q Amaral, Rubens Park, Denis R Morais, José Pontes, Vanessa R Guimaraes, Juliana A Camargo, Kátia Rm Leite, William C Nahas,[...]. Tumour Biol 2018
7
50

CYP17A1 and Androgen-Receptor Expression in Prostate Carcinoma Tissues and Cancer Cell Lines.
Alexandra Giatromanolaki, Virginia Fasoulaki, Dimitra Kalamida, Achilleas Mitrakas, Christos Kakouratos, Theodoros Lialiaris, Michael I Koukourakis. Curr Urol 2019
5
50

Snail1 transcription factor controls telomere transcription and integrity.
Rocco Mazzolini, Núria Gonzàlez, Andrea Garcia-Garijo, Alba Millanes-Romero, Sandra Peiró, Susan Smith, Antonio García de Herreros, Sílvia Canudas. Nucleic Acids Res 2018
14
50

Danazol Treatment for Telomere Diseases.
Danielle M Townsley, Bogdan Dumitriu, Delong Liu, Angélique Biancotto, Barbara Weinstein, Christina Chen, Nathan Hardy, Andrew D Mihalek, Shilpa Lingala, Yun Ju Kim,[...]. N Engl J Med 2016
164
50

The dark side of ZNF217, a key regulator of tumorigenesis with powerful biomarker value.
Pascale A Cohen, Caterina F Donini, Nhan T Nguyen, Hubert Lincet, Julie A Vendrell. Oncotarget 2015
30
50

Telomere length-dependent transcription and epigenetic modifications in promoters remote from telomere ends.
Ananda Kishore Mukherjee, Shalu Sharma, Suman Sengupta, Dhurjhoti Saha, Pankaj Kumar, Tabish Hussain, Vivek Srivastava, Sumitabho Deb Roy, Jerry W Shay, Shantanu Chowdhury. PLoS Genet 2018
24
50


Correlating breakage-fusion-bridge events with the overall chromosomal instability and in vitro karyotype evolution in prostate cancer.
B Vukovic, B Beheshti, P Park, G Lim, J Bayani, M Zielenska, J A Squire. Cytogenet Genome Res 2007
40
50

A triad of telomerase, androgen receptor and early growth response 1 in prostate cancer cells.
Sheeba Jacob, Sumeet Nayak, Ruchi Kakar, Uddhav K Chaudhari, Dolly Joshi, Babu R Vundinti, Gwendolyn Fernandes, Ram S Barai, Sanjeeva D Kholkute, Geetanjali Sachdeva. Cancer Biol Ther 2016
6
50

Telomerase activity: a prevalent marker of malignant human prostate tissue.
H J Sommerfeld, A K Meeker, M A Piatyszek, G S Bova, J W Shay, D S Coffey. Cancer Res 1996
370
50

Telomere DNA content in prostate biopsies predicts early rise in prostate-specific antigen after radical prostatectomy for prostate cancer.
Eric G Treat, Christopher M Heaphy, Larry W Massie, Marco Bisoffi, Anthony Y Smith, Michael S Davis, Jeffrey K Griffith. Urology 2010
18
50

Elevation of androgen receptor promotes prostate cancer metastasis by induction of epithelial-mesenchymal transition and reduction of KAT5.
Ching-Yu Lin, Yee-Jee Jan, Li-Kuo Kuo, Bi-Juan Wang, Chieh Huo, Shih Sheng Jiang, Shyh-Chang Chen, Ying-Yu Kuo, Chuang-Rung Chang, Chih-Pin Chuu. Cancer Sci 2018
15
50

GEPIA2: an enhanced web server for large-scale expression profiling and interactive analysis.
Zefang Tang, Boxi Kang, Chenwei Li, Tianxiang Chen, Zemin Zhang. Nucleic Acids Res 2019
426
50

Initial sequencing and analysis of the human genome.
E S Lander, L M Linton, B Birren, C Nusbaum, M C Zody, J Baldwin, K Devon, K Dewar, M Doyle, W FitzHugh,[...]. Nature 2001
50

Identification of retinoid acid induced 16 as a novel androgen receptor target in prostate cancer cells.
Cui-Ling Ding, Chun-Lin Qian, Zhong-Tian Qi, Wen Wang. Mol Cell Endocrinol 2020
1
100

The presence of androgen receptor elements regulates ZEB1 expression in the absence of androgen receptor.
Steven M Mooney, Princy Parsana, James R Hernandez, Xin Liu, James E Verdone, Gonzalo Torga, Calvin A Harberg, Kenneth J Pienta. J Cell Biochem 2015
9
50

Association between cancer-free survival and telomere DNA content in prostate tumors.
Colleen A Fordyce, Christopher M Heaphy, Nancy E Joste, Anthony Y Smith, William C Hunt, Jeffrey K Griffith. J Urol 2005
56
50

Zinc finger proteins in cancer progression.
Jayu Jen, Yi-Ching Wang. J Biomed Sci 2016
104
50

Androgen Signaling in Prostate Cancer.
Charles Dai, Hannelore Heemers, Nima Sharifi. Cold Spring Harb Perspect Med 2017
99
50

Determinants of telomere length across human tissues.
Kathryn Demanelis, Farzana Jasmine, Lin S Chen, Meytal Chernoff, Lin Tong, Dayana Delgado, Chenan Zhang, Justin Shinkle, Mekala Sabarinathan, Hannah Lin,[...]. Science 2020
44
50


Characterization of a zinc-finger protein and its association with apoptosis in prostate cancer cells.
G T Chang, M Steenbeek, E Schippers, L J Blok, W M van Weerden, D C van Alewijk, B H Eussen, G J van Steenbrugge, A O Brinkmann. J Natl Cancer Inst 2000
45
50

Androgen receptor interacts with telomeric proteins in prostate cancer cells.
Sahn-Ho Kim, Michelle Richardson, Kannagi Chinnakannu, V Uma Bai, Mani Menon, Evelyn R Barrack, G Prem-Veer Reddy. J Biol Chem 2010
19
50


Mammalian Rap1 controls telomere function and gene expression through binding to telomeric and extratelomeric sites.
Paula Martinez, Maria Thanasoula, Ana R Carlos, Gonzalo Gómez-López, Agueda M Tejera, Stefan Schoeftner, Orlando Dominguez, David G Pisano, Madalena Tarsounas, Maria A Blasco. Nat Cell Biol 2010
162
50

Prostate cancer cell telomere length variability and stromal cell telomere length as prognostic markers for metastasis and death.
Christopher M Heaphy, Ghil Suk Yoon, Sarah B Peskoe, Corinne E Joshu, Thomas K Lee, Edward Giovannucci, Lorelei A Mucci, Stacey A Kenfield, Meir J Stampfer, Jessica L Hicks,[...]. Cancer Discov 2013
48
50

Annual Report to the Nation on the Status of Cancer, part II: Recent changes in prostate cancer trends and disease characteristics.
Serban Negoita, Eric J Feuer, Angela Mariotto, Kathleen A Cronin, Valentina I Petkov, Sarah K Hussey, Vicki Benard, S Jane Henley, Robert N Anderson, Stacey Fedewa,[...]. Cancer 2018
102
50

Can telomere alterations predict biochemical recurrence in prostate adenocarcinoma? A preliminary study.
Dilek Ertoy Baydar, Haluk Ozen, Pinar O Geyik, Bora Gurel. Pathol Res Pract 2010
7
50

Telomeres and telomerase.
Simon R W L Chan, Elizabeth H Blackburn. Philos Trans R Soc Lond B Biol Sci 2004
308
50

Transcriptional silencing of zinc finger protein 185 identified by expression profiling is associated with prostate cancer progression.
Donkena Krishna Vanaja, John C Cheville, Steve J Iturria, Charles Y F Young. Cancer Res 2003
228
50

Telomere lengths differ significantly between small-cell neuroendocrine prostate carcinoma and adenocarcinoma of the prostate.
Christopher M Heaphy, Michael C Haffner, Mindy K Graham, David Lim, Christine Davis, Eva Corey, Jonathan I Epstein, Mario A Eisenberger, Hao Wang, Angelo M De Marzo,[...]. Hum Pathol 2020
1
100

Androgen receptor signaling in prostate cancer.
Zoran Culig, Frédéric R Santer. Cancer Metastasis Rev 2014
87
50

Zinc Finger 280B regulates sGCα1 and p53 in prostate cancer cells.
Shuai Gao, Chen-Lin Hsieh, Jun Zhou, Lirim Shemshedini. PLoS One 2013
10
50

The Heterogeneity of Prostate Cancer: A Practical Approach.
Yuri Tolkach, Glen Kristiansen. Pathobiology 2018
33
50


Prostate Cancer Genomic Subtypes.
Michael Fraser, Alexandre Rouette. Adv Exp Med Biol 2019
2
50


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.